dscCfaE recombinant vaccine (USAMRMC)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NamedscCfaE recombinant vaccine (USAMRMC)

Drug Alias NamedscCfaE (USAMRMC)recombinant E coli protein vaccine (USAMRMC)

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsEscherichia coli Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesU.S. Army Medical Research And Materiel Command

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesU.S. Army Medical Research And Materiel Command

Active IndicationsN/A

Inactive IndicationsEscherichia coli Infections

Other Information

ATC CodeN/A